Midgard Science

Bachem

Torrance, CA, United Statesbachem.comFrom their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Bachem develops and manufactures peptides and oligonucleotides as APIs for pharmaceutical and biotechnology companies. It supports projects from early research and clinical development through commercial GMP supply, with sites in Switzerland, the United States, and the United Kingdom.

Services

  • Peptide clinical development

    Supports peptide API programs from pre-clinical development through Phase I–III trials and market approval preparation, with research-grade and GMP-grade material, process development, and analytical support.

  • Peptide NCE development

    Supports peptide new chemical entities through clinical development with CMC services, process development, and analytical support.

  • Custom peptide synthesis

    Manufactures custom peptides for research needs using non-GMP synthesis, chemical modifications, analytical services, documentation, and aliquoting.

  • Catalog peptides

    Provides catalog peptides for research use.

  • Peptide commercial manufacturing

    Manufactures peptide APIs at commercial GMP scale.

    CDMO: development & manufacturing

  • Oligonucleotide clinical development

    Supports oligonucleotide API programs from pre-clinical development through Phase I–III trials and market approval preparation with analytical and process development support.

  • Oligonucleotide NCE development

    Supports oligonucleotide new chemical entities through clinical development with platform-ready analytical methods, process development, and a risk-mitigated CMC framework.

  • Oligonucleotide commercial manufacturing

    Manufactures oligonucleotide APIs at commercial GMP scale.

    CDMO: development & manufacturing

10 more services
  • Project management
  • Quality and regulatory support
  • Analytical capabilities
  • Supply and vertical integration
  • Clinical development for peptides
  • Commercial manufacturing of peptides
  • Catalog products
  • Clinical development for oligonucleotides
  • Commercial manufacturing of oligonucleotides
  • Quality and regulatory
What to send
  • Non-GMP peptide synthesis: 5 mg to 100 g
  • Aliquoting starting at 0.5 mg per vial

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Antibody
  • Peptide
  • Oligonucleotide
  • HPLC
  • LC-MS/MS
  • NMR
Capacity
  • 5 mg to 100 g for non-GMP peptide synthesis
  • Grams to tons for peptide API manufacturing
  • 4 GMP sites globally
  • 1 GMP production site in Switzerland for oligonucleotides
  • 4 GMP-certified sites across Switzerland and the United States
  • Milligrams to multi-tonne commercial volumes
  • Four GMP-certified sites across Switzerland and the United States
Offers
Stock compounds · Custom synthesis
Scales
Milligram · Gram · Kilogram · Ton
Data supplied
NMR · HPLC

Equipment

  • UHPLC
  • HPLC
  • 2D-UHPLC
  • GC
  • IC
  • TLC
  • MCSGP
  • ESI-Orbitrap
  • ESI-Q-ToF
  • MALDI-ToF/ToF
  • UHPLC / HPLC
  • UHPLC-MS/MS
  • HPLC-MS/MS
  • GC-MS/MS Triple Quadrupole
  • TLC-MS/MS
  • NMR

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: analytical capabilities, manufacturing, and clinical/commercial supply

Company

Type
CRDMO
Founded
1971
Team
2,500+ team members globally

Locations

Address
3132 Kashiwa Street Torrance, CA 90505 USA
Sites
Bubendorf, Switzerland · Vionnaz, Switzerland · Vista, United States · St. Helens, United Kingdom · Sisslerfeld, Switzerland
Serves
Worldwide, Switzerland, United States, pharma and biotech worldwide

Public records

Parent company
BACHEM HOLDING AG · CH GLEIF
FDA drug establishment registration
1000153019 · ANALYSIS; API MANUFACTURE source
Wikidata
Q4838851 source

Similar labs